On Stage and in Song

As part of his 2012 TedMed talk, the US National Institutes of Health Director Francis Collins says that the time between understanding the molecular cause of a disease and developing a drug to treat that disease is too long, and the process is too expensive. Collins further suggests that drugs that have been shown to be safe in humans — though not effective for their original target diseases — could be repurposed for other diseases, as the new National Center for Advancing Translational Sciences is aiming to do.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.